I Built a Model to Predict the FDA's July Vote on 7 Peptides
FDA / PCAC — official records & coverage — I Built a Model to Predict the FDA's July Vote on 7 Peptides
Channel: Barrick Health · Our label: Government proceedings and coverage of them · Source: youtube.com/watch?v=hs6sEjl6sv8
What this video covers
On July 23rd and 24th, an FDA advisory committee votes on seven peptides and the outcome decides whether a pharmacy can legally make them for you. The committee is the Pharmacy Compounding Advisory Committee or the PCAC. » [snorts] » Over those two days, it votes one peptide at a time on whether each one earns a spot on the list that lets compounding pharmacies prepare them. The seven under review are BBC157, TB500 Semax KPV MOTS-c Epitalon and Dihexa.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- On July 23rd and 24th, an FDA advisory committee votes on seven peptides and the outcome decides whether a pharmacy can legally make them for you.
- The seven under review are BBC157, TB500 Semax KPV MOTS-c Epitalon and Dihexa.
- If the vote is yes, your pharmacy can compound that peptide with a prescription.
- The committee is not certifying these peptides as safe and effective the way it would a new prescription drug.
- How precisely we can define and reproduce the exact molecule, the human safety record, evidence that it works for the use being proposed, and whether pharmacies have a real history compounding it.
- Category two is the FDA’s bucket for substances it considers a possible safety risk.
Read next
- TB-500 — compound page
- MOTS-c — compound page
- Epitalon — compound page
- Semax — compound page
- KPV — compound page
- Dihexa — more videos
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.